Atlas Trials

A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization

Clinical trial NCT01850030 · COMPLETED

Trial details

NCT number
NCT01850030
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Female Infertility
Start date
2013-08-01
Primary completion
2016-03-01
Enrollment
1070

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.